
Sign up to save your podcasts
Or


Dr Fontanarosa provides summary and commentary on the April 18, 2012 issue of JAMA, the Journal of the American Medical Association. Bevacizumab and Non–Small Cell Lung Cancer Survival, Helicopter vs Ground EMS and Trauma Survival, Radiation Therapy Choices and Prostate Cancer Morbidity, Survival After Open vs Endovascular Repair of AAA, Survival After Partial vs Radical Nephrectomy, Setting PCORI's priorities, Changes to research regulations.
By JAMA Network3.9
127127 ratings
Dr Fontanarosa provides summary and commentary on the April 18, 2012 issue of JAMA, the Journal of the American Medical Association. Bevacizumab and Non–Small Cell Lung Cancer Survival, Helicopter vs Ground EMS and Trauma Survival, Radiation Therapy Choices and Prostate Cancer Morbidity, Survival After Open vs Endovascular Repair of AAA, Survival After Partial vs Radical Nephrectomy, Setting PCORI's priorities, Changes to research regulations.

327 Listeners

546 Listeners

705 Listeners

500 Listeners

302 Listeners

260 Listeners

908 Listeners

3,382 Listeners

1,148 Listeners

90 Listeners

515 Listeners

363 Listeners

265 Listeners

438 Listeners

271 Listeners